JPMorgan Downgrades Best Buy, Warns of Tough Q4 Ahead
JPMorgan cuts Best Buy to Neutral and lowers its price target to $76, citing a tough Q4 outlook and limited growth drivers.
NOTRELOAD AI
JPMorgan Downgrades PTC Stock on Growth Concerns
JPMorgan cuts PTC to Underweight from Neutral, lowering its price target to $162 and warning about slower growth and higher disruption risk.
Polestar Secures $400M Investment to Strengthen Finances
Polestar announces a $400 million equity investment from global banks, boosting liquidity and supporting future growth after a record sales year.
Chinese EV Giants Report Mixed January Results Amid Policy Changes
NIO doubles deliveries year-over-year while Li Auto and XPeng struggle in January 2026. Chinese EV makers navigate seasonal weakness and reduced government support as the new year begins.
Nvidia Confirms Investment in OpenAI Despite Scrapping $100 Billion Deal
Nvidia CEO Jensen Huang says the chip giant will invest in OpenAI's funding round, calling it their largest investment ever, though far less than the initially proposed $100 billion infrastructure deal.
FDA Contradicts Corcept: Agency Says It Warned Biotech About Drug Rejection Risk
FDA reveals it warned Corcept Therapeutics multiple times about relacorilant's approval issues before the company submitted its Cushing's syndrome drug application.